Uday P. Pratap

1.2k total citations
49 papers, 682 citations indexed

About

Uday P. Pratap is a scholar working on Molecular Biology, Genetics and Endocrinology, Diabetes and Metabolism. According to data from OpenAlex, Uday P. Pratap has authored 49 papers receiving a total of 682 indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Molecular Biology, 16 papers in Genetics and 9 papers in Endocrinology, Diabetes and Metabolism. Recurrent topics in Uday P. Pratap's work include Estrogen and related hormone effects (16 papers), Stress Responses and Cortisol (8 papers) and Menopause: Health Impacts and Treatments (8 papers). Uday P. Pratap is often cited by papers focused on Estrogen and related hormone effects (16 papers), Stress Responses and Cortisol (8 papers) and Menopause: Health Impacts and Treatments (8 papers). Uday P. Pratap collaborates with scholars based in United States, India and China. Uday P. Pratap's co-authors include Ratna K. Vadlamudi, Gangadhara R. Sareddy, Rajeshwar R. Tekmal, Darrell W. Brann, Yujiao Lu, Quanguang Zhang, Srinivasan ThyagaRajan, Hannah P. Priyanka, Fu‐Lei Tang and Jing Wang and has published in prestigious journals such as Journal of Neuroscience, Cancer Research and International Journal of Molecular Sciences.

In The Last Decade

Uday P. Pratap

43 papers receiving 672 citations

Peers

Countries citing papers authored by Uday P. Pratap

Since Specialization

Citations

This map shows the geographic impact of Uday P. Pratap's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Uday P. Pratap with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Uday P. Pratap more than expected).

Fields of papers citing papers by Uday P. Pratap

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Uday P. Pratap. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Uday P. Pratap. The network helps show where Uday P. Pratap may publish in the future.

Co-authorship network of co-authors of Uday P. Pratap

This figure shows the co-authorship network connecting the top 25 collaborators of Uday P. Pratap. A scholar is included among the top collaborators of Uday P. Pratap based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Uday P. Pratap. Uday P. Pratap is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	PELP1 Is a Novel Therapeutic Target in Hepatocellular Carcinoma 2024 ·Cancer Research Communications ·(unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), Zhao Lai, Yidong Chen, Gangadhara R. Sareddy, Suryavathi Viswanadhapalli, Lu‐Zhe Sun, Ratna K. Vadlamudi, Uday P. Pratap	1
2	Abstract 2099: PELP1 inhibition enhances the therapeutic efficacy of topoisomerase inhibitors in triple-negative breast cancer 2024 ·Cancer Research ·Khaled Nassar, (unknown), (unknown), Behnam Ebrahimi, Xue Yang, Uday P. Pratap, Salvador Alejo, Gangadhara R. Sareddy, Suryavathi Viswanadhapalli, Ratna K. Vadlamudi	0
3	Estrogen-receptor status determines differential regulation of α1- and α2-adrenoceptor-mediated cell survival, angiogenesis, and intracellular signaling responses in breast cancer cell lines 2024 ·Medical Oncology ·Hannah P. Priyanka, Uday P. Pratap, (unknown), (unknown), Srinivasan ThyagaRajan	3
4	Pharmacological inhibition of KDM1A/LSD1 enhances estrogen receptor beta-mediated tumor suppression in ovarian cancer 2023 ·Cancer Letters ·Prabhakar Pitta Venkata, (unknown), Yi He, Salvador Alejo, (unknown), (unknown), Uday P. Pratap, Yihong Chen, Zexuan Liu, Yi Zou, Zhao Lai, Takayoshi Suzuki, Suryavathi Viswanadhapalli, Susan T. Weintraub, Srinath Palakurthi, Philip T. Valente, Rajeshwar R. Tekmal, Edward R. Kost, Ratna K. Vadlamudi, Gangadhara R. Sareddy	15
5	Targeting PELP1 oncogenic signaling in TNBC with the small molecule inhibitor SMIP34 2023 ·Breast Cancer Research and Treatment ·(unknown), Uday P. Pratap, Zexuan Liu, Junhao Liu, (unknown), Xue Yang, Behnam Ebrahimi, (unknown), (unknown), Gangadhara R. Sareddy, Suryavathi Viswanadhapalli, Manjeet K. Rao, Ratna K. Vadlamudi	5
6	Preclinical Development of Brain Permeable ERβ Agonist for the Treatment of Glioblastoma 2023 ·Molecular Cancer Therapeutics ·Uday P. Pratap, Michael Tidwell, (unknown), (unknown), (unknown), Suryavathi Viswanadhapalli, Gangadhara R. Sareddy, Dong Liang, Huan Xie, Yidong Chen, Zhao Lai, Rajeshwar R. Tekmal, Stanton F. McHardy, Andrew Brenner, Ratna K. Vadlamudi	4
7	Development and Characterization of Inducible Astrocyte-Specific Aromatase Knockout Mice 2023 ·Biology ·Jing Wang, Uday P. Pratap, Yujiao Lu, Gangadhara R. Sareddy, Rajeshwar R. Tekmal, Ratna K. Vadlamudi, Darrell W. Brann	1
8	Insight into Methanobiology and Role of Emerging Technologies in Methane Management 2023 ·Abhishek Singh, Karen Ghazaryan, Hasmik S. Movsesyan, Αθανάσιος Αλεξίου, (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), Uday P. Pratap, (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown)	3
9	Alterations in Immune Responses Are Associated with Dysfunctional Intracellular Signaling in Peripheral Blood Mononuclear Cells of Men and Women with Mild Cognitive Impairment and Alzheimer’s disease 2023 ·Molecular Neurobiology ·(unknown), Hannah P. Priyanka, (unknown), (unknown), Uday P. Pratap, (unknown), Srinivasan ThyagaRajan	5
10	Therapeutic Targeting of Ovarian Cancer Stem Cells Using Estrogen Receptor Beta Agonist 2022 ·International Journal of Molecular Sciences ·Yi He, Salvador Alejo, Prabhakar Pitta Venkata, (unknown), (unknown), Uday P. Pratap, Yi Zou, Zhao Lai, Rajeshwar R. Tekmal, Edward R. Kost, Gangadhara R. Sareddy	14
11	KDM1A inhibition augments the efficacy of rapamycin for the treatment of endometrial cancer 2021 ·Cancer Letters ·Prabhakar Pitta Venkata, Yihong Chen, Salvador Alejo, Yi He, (unknown), (unknown), Junhao Liu, Uday P. Pratap, (unknown), (unknown), Yi Zou, Zhao Lai, Takayoshi Suzuki, Suryavathi Viswanadhapalli, Srinath Palakurthi, Rajeshwar R. Tekmal, Ratna K. Vadlamudi, Edward R. Kost, Gangadhara R. Sareddy	16
12	LIF/LIFR oncogenic signaling is a novel therapeutic target in endometrial cancer 2021 ·Cell Death Discovery ·Weiwei Tang, Kumaraguruparan Ramasamy, (unknown), Bindu Santhamma, (unknown), Prabhakar Pitta Venkata, (unknown), Junhao Liu, Zexuan Liu, (unknown), Behnam Ebrahimi, Uday P. Pratap, Xiao‐Nan Li, Philip T. Valente, Edward R. Kost, Gangadhara R. Sareddy, Ratna K. Vadlamudi, (unknown), Rajeshwar R. Tekmal, Suryavathi Viswanadhapalli	19
13	Neuron-Derived Estrogen Is Critical for Astrocyte Activation and Neuroprotection of the Ischemic Brain 2020 ·Journal of Neuroscience ·Yujiao Lu, Gangadhara R. Sareddy, Jing Wang, Quanguang Zhang, Fu‐Lei Tang, Uday P. Pratap, Rajeshwar R. Tekmal, Ratna K. Vadlamudi, Darrell W. Brann	84
14	Age-associated decline in neural, endocrine, and immune responses in men and women: Involvement of intracellular signaling pathways 2020 ·Journal of Neuroimmunology ·(unknown), (unknown), (unknown), (unknown), Uday P. Pratap, Hannah P. Priyanka, (unknown), Srinivasan ThyagaRajan	6
15	KDM1A inhibition is effective in reducing stemness and treating triple negative breast cancer 2020 ·Breast Cancer Research and Treatment ·Mei Zhou, Prabhakar Pitta Venkata, Suryavathi Viswanadhapalli, (unknown), Salvador Alejo, Yihong Chen, Yi He, Uday P. Pratap, Junhao Liu, Yi Zou, Zhao Lai, Takayoshi Suzuki, Andrew Brenner, Rajeshwar R. Tekmal, Ratna K. Vadlamudi, Gangadhara R. Sareddy	32
16	Virgin coconut oil supplementation in diet modulates immunity mediated through survival signaling pathways in rats 2019 ·Journal of Complementary and Integrative Medicine ·(unknown), Uday P. Pratap, (unknown), (unknown), (unknown), Srinivasan ThyagaRajan	4
17	Estrogen receptor coregulator binding modulator (ERX-11) enhances the activity of CDK4/6 inhibitors against estrogen receptor-positive breast cancers 2019 ·Breast Cancer Research ·Suryavathi Viswanadhapalli, Shihong Ma, Gangadhara R. Sareddy, Tae-Kyung Lee, Mengxing Li, (unknown), Xihui Liu, (unknown), Uday P. Pratap, Mei Zhou, (unknown), (unknown), Carlos L. Arteaga, Prasanna Alluri, Manjeet K. Rao, Susan T. Weintraub, Rajeshwar R. Tekmal, Jung‐Mo Ahn, Ganesh V. Raj, Ratna K. Vadlamudi	16
18	Estrogen-induced neuroimmunomodulation as facilitator of and barrier to reproductive aging in brain and lymphoid organs 2018 ·Journal of Chemical Neuroanatomy ·Srinivasan ThyagaRajan, (unknown), Uday P. Pratap, Hannah P. Priyanka, (unknown)	14
19	Phytochemicals inMorinda citrifoliafruit selectively modulate age-associated immunity and antioxidant enzyme activities through ERK pathway in splenic lymphocytes of male F344 rats 2015 ·Journal of Receptors and Signal Transduction ·Uday P. Pratap, (unknown), (unknown), (unknown), Hannah P. Priyanka, Srinivasan ThyagaRajan	7
20	Estrogen upregulates inflammatory signals through NF-κB, IFN-γ, and nitric oxide via Akt/mTOR pathway in the lymph node lymphocytes of middle-aged female rats 2015 ·International Immunopharmacology ·Uday P. Pratap, Himanshu Sharma, (unknown), (unknown), (unknown), (unknown), Hannah P. Priyanka, Srinivasan ThyagaRajan	24

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact